INCLINE VILLAGE, Nev.
Nov. 1, 2012
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its third quarter financial results for the period ended
September 30, 2012
Monday, November 5, 2012
, after market close. PDL's management will host a conference call and webcast that day at
4:30 p.m. Eastern Time
to discuss the financial results. A slide presentation relating to the call will be available via the webcast link on the PDL website.
Conference Call Details
To access the live conference call via phone, please dial (877) 303-9145 from
the United States
or (760) 536-5203 internationally. The conference ID is 55617262. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through
November 12, 2012
, and may be accessed by dialing (855) 859-2056 from
the United States
or (404) 537-3406 internationally. The replay passcode is 55617262.
To access the live and subsequently archived webcast of the conference call, go to the Company's website at
and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new revenue generating assets and maximizing value for its shareholders. For more information, please visit
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.